Medtronic Price to Sales Ratio 2010-2025 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of July 01, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-01 | 88.75 | 3.41 | |
| 2025-04-30 | 84.06 | $26.01 | 3.23 |
| 2025-01-31 | 89.36 | $25.54 | 3.50 |
| 2024-10-31 | 87.07 | $25.17 | 3.46 |
| 2024-07-31 | 77.74 | $24.63 | 3.16 |
| 2024-04-30 | 76.98 | $24.30 | 3.17 |
| 2024-01-31 | 83.29 | $24.25 | 3.43 |
| 2023-10-31 | 66.58 | $23.98 | 2.78 |
| 2023-07-31 | 82.11 | $23.68 | 3.47 |
| 2023-04-30 | 84.43 | $23.43 | 3.60 |
| 2023-01-31 | 77.03 | $23.00 | 3.35 |
| 2022-10-31 | 79.68 | $22.95 | 3.47 |
| 2022-07-31 | 83.73 | $23.05 | 3.63 |
| 2022-04-30 | 93.73 | $23.41 | 4.00 |
| 2022-01-31 | 92.40 | $23.47 | 3.94 |
| 2021-10-31 | 106.33 | $23.46 | 4.53 |
| 2021-07-31 | 115.92 | $23.33 | 4.97 |
| 2021-04-30 | 115.00 | $22.26 | 5.17 |
| 2021-01-31 | 97.30 | $20.65 | 4.71 |
| 2020-10-31 | 87.46 | $20.62 | 4.24 |
| 2020-07-31 | 83.43 | $20.67 | 4.04 |
| 2020-04-30 | 83.87 | $21.39 | 3.92 |
| 2020-01-31 | 98.56 | $22.96 | 4.29 |
| 2019-10-31 | 92.53 | $22.82 | 4.05 |
| 2019-07-31 | 86.18 | $22.62 | 3.81 |
| 2019-04-30 | 74.67 | $22.48 | 3.32 |
| 2019-01-31 | 73.91 | $22.44 | 3.29 |
| 2018-10-31 | 74.69 | $22.30 | 3.35 |
| 2018-07-31 | 74.65 | $21.96 | 3.40 |
| 2018-04-30 | 65.91 | $21.93 | 3.01 |
| 2018-01-31 | 70.24 | $21.67 | 3.24 |
| 2017-10-31 | 65.48 | $21.49 | 3.05 |
| 2017-07-31 | 67.88 | $21.60 | 3.14 |
| 2017-04-30 | 66.82 | $21.32 | 3.13 |
| 2017-01-31 | 60.81 | $20.94 | 2.90 |
| 2016-10-31 | 65.22 | $20.55 | 3.17 |
| 2016-07-31 | 69.34 | $20.21 | 3.43 |
| 2016-04-30 | 62.32 | $20.19 | 3.09 |
| 2016-01-31 | 59.47 | $21.47 | 2.77 |
| 2015-10-31 | 57.62 | $20.93 | 2.75 |
| 2015-07-31 | 60.77 | $20.38 | 2.98 |
| 2015-04-30 | 57.43 | $19.57 | 2.93 |
| 2015-01-31 | 54.86 | $17.49 | 3.14 |
| 2014-10-31 | 52.15 | $17.27 | 3.02 |
| 2014-07-31 | 47.01 | $17.03 | 2.76 |
| 2014-04-30 | 44.57 | $16.78 | 2.66 |
| 2014-01-31 | 42.66 | $16.62 | 2.57 |
| 2013-10-31 | 43.08 | $16.44 | 2.62 |
| 2013-07-31 | 41.25 | $16.27 | 2.54 |
| 2013-04-30 | 34.67 | $16.13 | 2.15 |
| 2013-01-31 | 34.42 | $15.85 | 2.17 |
| 2012-10-31 | 30.52 | $15.60 | 1.96 |
| 2012-07-31 | 28.76 | $15.40 | 1.87 |
| 2012-04-30 | 27.69 | $15.22 | 1.82 |
| 2012-01-31 | 27.79 | $14.84 | 1.87 |
| 2011-10-31 | 24.87 | $14.73 | 1.69 |
| 2011-07-31 | 25.61 | $14.54 | 1.76 |
| 2011-04-30 | 29.47 | $14.32 | 2.06 |
| 2011-01-31 | 26.90 | $14.04 | 1.92 |
| 2010-10-31 | 24.58 | $13.94 | 1.76 |
| 2010-07-31 | 25.62 | $13.79 | 1.86 |
| 2010-04-30 | 30.09 | $13.86 | 2.17 |
| 2010-01-31 | 29.40 | $13.86 | 2.12 |
| 2009-10-31 | 24.36 | $13.50 | 1.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.799B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |